Israeli company TheraCoat, which develops systems for targeted drug delivery, has raised $7 million. The funds were raised from Pontifax and Chealth alongside private investors. The company, which specializes in drug delivery systems for internal cavities, specifically the bladder, says that it will use the funds for R&D, clinical trials, and the launch of sales.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

AI Can Predict Future Heart Attacks By Analyzing CT Scans
October 01, 2023

Israeli Startups Create Powerful Drone-Detecting Software
September 28, 2023

Model Sees Daylight As Boost For Hospitalized Patients’ Health
September 28, 2023

Solar Panels On A Roll Certified As Safe For Use In US, Europe
September 28, 2023
Facebook comments